JP2020513032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513032A5 JP2020513032A5 JP2020502532A JP2020502532A JP2020513032A5 JP 2020513032 A5 JP2020513032 A5 JP 2020513032A5 JP 2020502532 A JP2020502532 A JP 2020502532A JP 2020502532 A JP2020502532 A JP 2020502532A JP 2020513032 A5 JP2020513032 A5 JP 2020513032A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- sequestering
- metabolite
- behavioral symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762480039P | 2017-03-31 | 2017-03-31 | |
| US62/480,039 | 2017-03-31 | ||
| PCT/US2018/025607 WO2018183986A1 (en) | 2017-03-31 | 2018-03-31 | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513032A JP2020513032A (ja) | 2020-04-30 |
| JP2020513032A5 true JP2020513032A5 (https=) | 2021-04-15 |
| JP6978122B2 JP6978122B2 (ja) | 2021-12-08 |
Family
ID=63677186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502532A Expired - Fee Related JP6978122B2 (ja) | 2017-03-31 | 2018-03-31 | 自閉症および関連障害の治療および予防のための腸管選択的隔離剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US10617718B2 (https=) |
| EP (1) | EP3600349A4 (https=) |
| JP (1) | JP6978122B2 (https=) |
| KR (1) | KR102328323B1 (https=) |
| CN (2) | CN114569633B (https=) |
| AU (3) | AU2018243836B9 (https=) |
| BR (1) | BR112019020289A2 (https=) |
| CA (2) | CA3095724C (https=) |
| WO (1) | WO2018183986A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6978122B2 (ja) | 2017-03-31 | 2021-12-08 | アキシャル セラピューティクス，インク． | 自閉症および関連障害の治療および予防のための腸管選択的隔離剤 |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| WO2021011481A1 (en) * | 2019-07-12 | 2021-01-21 | The General Hospital Corporation | Anti-inflammatory factors |
| CN114829629A (zh) * | 2019-12-19 | 2022-07-29 | 希尔氏宠物营养品公司 | 治疗和降低患上与犬科动物的升高的4-乙基苯基硫酸盐相关的病状的风险的组合物和方法以及鉴定有风险患上此类病状的犬科动物的方法 |
| US20240197795A1 (en) * | 2020-07-27 | 2024-06-20 | Boadie DUNLOP | Assessment and treatment of depression, anxiety, or related disorders |
| CN113440522B (zh) * | 2021-07-29 | 2022-12-13 | 中山大学附属第七医院(深圳) | 一种吲哚丙酸在制备用于治疗自闭症药物中的应用 |
| CN115825314A (zh) * | 2021-09-17 | 2023-03-21 | 中国科学院深圳先进技术研究院 | 一种阿尔兹海默症生物标志物s-甲基-5′-硫代腺苷及其应用 |
| WO2023154547A1 (en) | 2022-02-14 | 2023-08-17 | Axial Therapeutics, Inc. | Colon targeted drug delivery |
| WO2023154966A1 (en) * | 2022-02-14 | 2023-08-17 | Axial Therapeutics, Inc. | Compositions and methods for sequestering metabolites in the gastrointestinal tract |
| CN116990395A (zh) * | 2022-04-26 | 2023-11-03 | 中国科学院深圳先进技术研究院 | 一种基于粪便的阿尔兹海默症生物标志物及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761284A (en) * | 1977-12-27 | 1988-08-02 | Kureha Kagaku Kogy Kabushiki Kaisha | Antidote including activated carbon particles |
| JPS5673542A (en) | 1979-11-22 | 1981-06-18 | Kureha Chem Ind Co Ltd | Adsorbent |
| GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
| US7651974B2 (en) | 2002-11-01 | 2010-01-26 | Kureha Chemical Industry Co., Ltd. | Adsorbent for oral administration |
| CN101084206A (zh) * | 2004-12-13 | 2007-12-05 | 艾尼纳制药公司 | 作为5ht2c受体调节剂以治疗与其相关病症的n－联芳基和n－芳基杂芳基2－经取代哌嗪衍生物 |
| WO2010102218A1 (en) * | 2009-03-05 | 2010-09-10 | Mithridion, Inc. | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| CN103491949B (zh) * | 2011-03-04 | 2017-02-08 | 株式会社吴羽 | 片剂型的口服给药用组合物及其制造方法 |
| WO2012161921A1 (en) * | 2011-05-23 | 2012-11-29 | Thomas Jefferson University | Intestinal hyperpermeability and prevention of systemic disease |
| GB201204696D0 (en) * | 2012-03-16 | 2012-05-02 | Ucl Business Plc | Therapy |
| WO2014036182A2 (en) | 2012-08-29 | 2014-03-06 | California Institute Of Technology | Diagnosis and treatment of autism spectrum disorder |
| TWI520751B (zh) | 2013-02-22 | 2016-02-11 | 吳羽股份有限公司 | 經口投予用吸附劑及腎疾病治療劑及肝疾病治療劑 |
| US10060932B2 (en) | 2013-07-09 | 2018-08-28 | Stemina Biomarker Discovery, Inc. | Biomarkers of autism spectrum disorder |
| JP2016525138A (ja) * | 2013-07-23 | 2016-08-22 | ユーロ−セルティーク エス．エイ． | 疼痛および腸内ディスバイオシスをもたらす疾患および／または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ |
| US9763903B2 (en) * | 2013-10-22 | 2017-09-19 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| US20150111878A1 (en) * | 2013-10-22 | 2015-04-23 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| US20170020999A1 (en) * | 2014-04-04 | 2017-01-26 | Biotechnobel Sa | Composition for prevention and/or treatment of chronic inflammation and concomitant biofilms in the gastrointestinal tract |
| JP6978122B2 (ja) | 2017-03-31 | 2021-12-08 | アキシャル セラピューティクス，インク． | 自閉症および関連障害の治療および予防のための腸管選択的隔離剤 |
-
2018
- 2018-03-31 JP JP2020502532A patent/JP6978122B2/ja not_active Expired - Fee Related
- 2018-03-31 WO PCT/US2018/025607 patent/WO2018183986A1/en not_active Ceased
- 2018-03-31 CA CA3095724A patent/CA3095724C/en active Active
- 2018-03-31 EP EP18778222.2A patent/EP3600349A4/en not_active Withdrawn
- 2018-03-31 CA CA3191747A patent/CA3191747A1/en active Pending
- 2018-03-31 AU AU2018243836A patent/AU2018243836B9/en not_active Ceased
- 2018-03-31 KR KR1020197032302A patent/KR102328323B1/ko not_active Expired - Fee Related
- 2018-03-31 CN CN202210138407.5A patent/CN114569633B/zh not_active Expired - Fee Related
- 2018-03-31 BR BR112019020289-7A patent/BR112019020289A2/pt not_active Application Discontinuation
- 2018-03-31 CN CN201880034095.5A patent/CN110944650B/zh not_active Expired - Fee Related
- 2018-05-31 US US15/994,571 patent/US10617718B2/en active Active
-
2020
- 2020-03-23 US US16/827,629 patent/US20200390809A1/en not_active Abandoned
- 2020-06-10 US US16/898,201 patent/US11007219B2/en not_active Expired - Fee Related
-
2021
- 2021-07-22 AU AU2021206871A patent/AU2021206871B2/en not_active Ceased
-
2022
- 2022-01-14 AU AU2022200220A patent/AU2022200220A1/en not_active Abandoned
-
2023
- 2023-06-30 US US18/345,279 patent/US20230364135A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020513032A5 (https=) | ||
| JP2018513107A5 (https=) | ||
| JP2021525729A5 (https=) | ||
| JP2014506321A5 (https=) | ||
| CN109310769A (zh) | 用rxr激动剂与甲状腺激素的组合的自身免疫疾病的治疗 | |
| WO2019235577A1 (ja) | 酸化ストレスに起因する疾患の予防又は治療剤 | |
| RU2019111096A (ru) | Лекарственные формы леводопы для быстрого купирования болезни паркинсона | |
| JP2020531543A (ja) | アマンタジン組成物、その調製、および使用方法 | |
| WO2015144059A1 (zh) | 具有镇咳活性的细辛总多糖提取物及其提取方法和应用 | |
| JP2018529747A5 (https=) | ||
| Mollica et al. | Obstructive sleep apnea and cardiovascular risks in the elderly population | |
| CN104161742A (zh) | 芬戈莫德及其结构类似物用于制备治疗脑出血药物的应用 | |
| JP4180258B2 (ja) | ＩｇＥ抗体抑制剤および食品 | |
| CN105496992A (zh) | 氨溴索沙丁胺醇脂质固体分散体 | |
| CN102641350B (zh) | 温肺平喘颗粒及其制备工艺 | |
| Lemko et al. | The usage of haloaerosoltherapy in the rehabilitational treatment of children with reccurent bronchitis | |
| CN105078899B (zh) | 一种恩诺沙星复层高分子矫味骨架微粒及其制备方法 | |
| CN105362246B (zh) | 氨溴索沙丁胺醇控释片的制备方法 | |
| CN105456201B (zh) | 氨溴索沙丁胺醇微丸的制备方法 | |
| RU2278670C2 (ru) | Способ лечения бронхиальной астмы у детей в период ремиссии | |
| JP2021525796A (ja) | 神経疾患の阻害 | |
| CN105456221B (zh) | 氨溴索沙丁胺醇肠溶颗粒的制备方法 | |
| CN107281492B (zh) | 一种组合物的用途 | |
| CN110152003B (zh) | 一种用于治疗copd的复方药物及其制备方法 | |
| CN105326804B (zh) | 氨溴索沙丁胺醇滴丸 |